Cargando…
Unveiling the molecular features, relevant immune and clinical characteristics of SIGLEC15 in thyroid cancer
The groundbreaking research work about SIGLEC15 has raised it as a potential promising target in cancer immunotherapy. Unfortunately, the role of SIGLEC15 in thyroid carcinoma (THCA) remains obscure. Public and home multi-omics data were collected to investigate the role of SIGLEC15 in THCA in our s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500188/ https://www.ncbi.nlm.nih.gov/pubmed/36159823 http://dx.doi.org/10.3389/fimmu.2022.975787 |